Institutional investors purchased a net $37.7 million shares of MRNA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 46.19% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 12.7 Million shares of Moderna Inc
BLACKROCK FUND ADVISORS Bought 5.0 Million shares of Moderna Inc
THE VANGUARD GROUP, INC. Bought 4.7 Million shares of Moderna Inc